MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-26-0092675
Batavia Pharma Private Limited - pharma in Pune, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹7.84 Cr
▲ 49% YoY
Net profit · FY 2025
₹1.31 Cr
Net margin 16.7%
EBITDA · FY 2025
₹2.19 Cr
EBITDA margin 27.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Employees · EPFO
20
Provident fund records
Directors on board
4
As per MCA filings
About Batavia Pharma Private Limited
Data last updated:
Batavia Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 October 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24304PN2016PTC166674. Its GSTIN is 27AAGCB9130R1Z3 (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Harish Nathalal Batavia and Tejas Harish Batavia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pune, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.84 Cr, a growth of 49% compared to the previous year. For the same year it recorded a net profit of ₹1.31 Cr (net margin 16.7%) and EBITDA of ₹2.19 Cr (EBITDA margin 27.9%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 23% over five years.
The company has about 20 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Batavia Pharma.
Batavia Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0092675). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bataviapharma.com.
Company Details of Batavia Pharma Private Limited
CIN U24304PN2016PTC166674
Registration Number 166674
Incorporation Date 04 October 2016
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-26-0092675
Key People
Harish Nathalal Batavia Director Tejas Harish Batavia Director Vishal Tinesh Batavia Director Recognitions & Rankings of Batavia Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressOffice No 5 – 6 Commerce Avenue Paud Road S.No 127/2 Pl No 22 – 24 Mahaganesh Col K, Othrud, Pune, Maharashtra, India – 411029
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Batavia Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Batavia Pharma Private Limited
Batavia Pharma operates one associated brand: Batavia Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Development, manufacturing, and commercialization of generic pharmaceuticals for global markets. | bataviapharma.com |
Business Activity of Batavia Pharma Private Limited
The main business activities of Batavia Pharma are professional, scientific and technical and trade. In detail, this covers scientific research and development and wholesale trading. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Batavia Pharma Private Limited FY 2025 filings available
Batavia Pharma Private Limited reported revenue of ₹7.84 Cr (up 49% YoY) for FY 2025.
Revenue · FY 2025
₹7.84 Cr ▲ 49%
Net profit · FY 2025
₹1.31 Cr margin 16.7%
EBITDA · FY 2025
₹2.19 Cr margin 27.9%
Compounded Annual Growth Rate (CAGR) of Batavia Pharma Private Limited
Revenue CAGR growth
1 year
▲ 49%
3 years · compounded
▲ 26%
5 years · compounded
▲ 23%
EBITDA CAGR growth
1 year
▲ 61%
3 years · compounded
▲ 61%
5 years · compounded
▲ 16%
Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 49% growth in the latest year. EBITDA rose 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Batavia Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.19 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.31 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Batavia Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 27.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 16.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Batavia Pharma are in the company report.
Premium access
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Batavia Pharma Private Limited
Batavia Pharma has 4 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harish Nathalal Batavia Also directs: Batavia Exports International LLP | Director | 04 Oct 2016 | 10 Years 0 Months | Current |
| Tejas Harish Batavia Also directs: Batavia Exports International LLP | Director | 04 Oct 2016 | 10 Years 0 Months | Current |
| Vishal Tinesh Batavia Also directs: Batavia Exports International LLP | Director | 04 Oct 2016 | 10 Years 0 Months | Current |
| Tinesh Nathalal Batavia Also directs: Batavia Exports International LLP | Director | 04 Oct 2016 | 10 Years 0 Months | Current |
Peer Comparison of Batavia Pharma Private Limited
Batavia Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Scientific research and development). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Infinia Sciences Private Limited | ₹8.07 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Pune, Maharashtra, India |
| CPL Biologicals Private Limited | ₹8.01 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Ahmedabad, Gujarat, India |
| Exa Mobility India Private Limited | ₹8.01 Cr (FY 2023) | •••• | •••• | 529.0% | •••• | Pune, Maharashtra, India |
| Chemicea Pharmaceuticals Private Limited | ₹7.88 Cr (FY 2024) | •••• | •••• | 46.0% | •••• | Panvel, Maharashtra, India |
| Vivotech Research Lab Private Limited | ₹7.86 Cr (FY 2025) | •••• | •••• | 454.0% | •••• | Thane, Maharashtra, India |
| Batavia Pharma Private Limited this company | ₹7.84 Cr (FY 2025) | •••• | •••• | 49.0% | •••• | Pune, Maharashtra, India |
| Cliniexperts Research Services Private Limited | ₹7.78 Cr (FY 2025) | •••• | •••• | 32.0% | •••• | Dwarka, New Delhi, Delhi, India |
| Sphaera Pharma Private Limited | ₹7.73 Cr (FY 2024) | •••• | •••• | 6.0% | •••• | New Delhi, Delhi, India |
| Cddep India Private Limited | ₹7.69 Cr (FY 2025) | •••• | •••• | -65.0% | •••• | Chickballapur, Karnataka, India |
| Super Scientific Sales Private Limited | ₹7.61 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | New Delhi, Delhi, India |
| Satyarx Pharma Innovations Private Limited | ₹7.55 Cr (FY 2025) | •••• | •••• | 24.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Batavia Pharma by revenue in the same principal business activity (Scientific research and development), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Batavia Pharma Private Limited
Batavia Pharma Private Limited is audited by Joshi & Kulkarni for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Joshi & Kulkarni | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Batavia Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Batavia Pharma Private Limited
Batavia Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
MSME Payment Delays by Batavia Pharma Private Limited
Batavia Pharma Private Limited has 7 MSME Form 1 returns on record between 2018 and 2021, listing 101 overdue payments to 30 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 30)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Gpax Pharmaceuticals Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Ymc India Private Limited | •••• | •••• | •••• |
| Universal Calibration Services Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Premium access
Full MSME payment history
Every supplier, amount and due date from all 7 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Batavia Pharma Private Limited
Employment history and EPFO contributions of people linked to Batavia Pharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Batavia Pharma Private Limited
Batavia Pharma Private Limited has 4 board changes on record since 2016: 4 appointments. The latest: Harish Nathalal Batavia was appointed as Director on 04 Oct 2016.
AGM
Batavia Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Batavia Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Appointed
Harish Nathalal Batavia was appointed as Director.
Appointed
Tejas Harish Batavia was appointed as Director.
Appointed
Tinesh Nathalal Batavia was appointed as Director.
Appointed
Vishal Tinesh Batavia was appointed as Director.
Incorporation
04 Oct 2016
Batavia Pharma Private Limited was registered on 04 Oct 2016 with Roc Pune & aged 10 years 16 days as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Batavia Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Batavia Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Batavia Pharma Private Limited
Batavia Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCB9130R1Z3 | Maharashtra | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Batavia Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Batavia Pharma Private Limited
Batavia Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 October 2016 (10+ years old) and is registered under CIN U24304PN2016PTC166674.
Batavia Pharma reported revenue of ₹7.84 Cr for FY 2025 (up 49% YoY).
Batavia Pharma has 4 current directors:
- Harish Nathalal Batavia - Director
- Tejas Harish Batavia - Director
- Vishal Tinesh Batavia - Director
- Tinesh Nathalal Batavia - Director
Batavia Pharma reported a net profit of ₹1.31 Cr (net margin 16.7%) and EBITDA of ₹2.19 Cr (EBITDA margin 27.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Batavia Pharma is 26% over three years and 23% over five years. In the latest year (FY 2025) revenue rose 49%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Batavia Pharma is 27AAGCB9130R1Z3, registered in Maharashtra.
The CIN (Corporate Identification Number) of Batavia Pharma is U24304PN2016PTC166674. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Batavia Pharma was incorporated on 04 October 2016, making it 10+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Batavia Pharma by revenue are Infinia Sciences Private Limited, CPL Biologicals Private Limited, Exa Mobility India Private Limited, Chemicea Pharmaceuticals Private Limited, Vivotech Research Lab Private Limited and 5 more, all in the same principal business activity (Scientific research and development).
Harish Nathalal Batavia was appointed as Director on 04 Oct 2016. Tejas Harish Batavia was appointed as Director on 04 Oct 2016. Tinesh Nathalal Batavia was appointed as Director on 04 Oct 2016. Batavia Pharma has 4 board changes on record in total.
Yes, Batavia Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-MH-26-0092675).
Batavia Pharma has 7 MSME Form 1 returns on record between 2018 and 2021, listing 101 overdue payments to 30 micro and small suppliers. The latest return was filed on 09 Aug 2022.